Geneos Wealth Management’s Goldman Sachs ActiveBeta US Large Cap Equity ETF GSLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.7K Buy
308
+47
+18% +$6.5K ﹤0.01% 1511
2026
Q1
$32.7K Hold
261
– – ﹤0.01% 1591
2025
Q4
$34.6K Hold
261
– – ﹤0.01% 1535
2025
Q3
$34K Sell
261
-196
-43% -$24.7K ﹤0.01% 1519
2025
Q2
$55.5K Buy
457
+196
+75% +$22.1K ﹤0.01% 1512
2025
Q1
$28.7K Hold
261
– – ﹤0.01% 1758
2024
Q4
$30.1K Hold
261
– – ﹤0.01% 1538
2024
Q3
$29.5K Hold
261
– – ﹤0.01% 1399
2024
Q2
$27.9K Hold
261
– – ﹤0.01% 1250
2024
Q1
$27.1K Sell
261
-350
-57% -$34.5K ﹤0.01% 1268
2023
Q4
$57.3K Hold
611
– – ﹤0.01% 1019
2023
Q3
$51.5K Hold
611
– – ﹤0.01% 1071
2023
Q2
$53.3K Hold
611
– – ﹤0.01% 1062
2023
Q1
$49.6K Buy
611
+113
+23% +$8.96K ﹤0.01% 1088
2022
Q4
$37.9K Sell
498
-210
-30% -$16.1K ﹤0.01% 1148
2022
Q3
$50K Buy
708
+203
+40% +$16K ﹤0.01% 1027
2022
Q2
$38K Hold
505
– – ﹤0.01% 1398
2022
Q1
$44K Hold
505
– – ﹤0.01% 1440
2021
Q4
$48K Buy
505
+268
+113% +$24.6K ﹤0.01% 1499
2021
Q3
$20K Buy
237
+74
+45% +$6.57K ﹤0.01% 1913
2021
Q2
$14K Hold
163
– – ﹤0.01% 2075
2021
Q1
$13K Hold
163
– – ﹤0.01% 2261
2020
Q4
$12K Hold
163
– – ﹤0.01% 2143
2020
Q3
$10K Hold
163
– – ﹤0.01% 1941
2020
Q2
$9K Hold
163
– – ﹤0.01% 1945
2020
Q1
$8K Buy
+163
New +$10.1K ﹤0.01% 1885
2018
Q4
– Sell
-1,497
Closed -$87K – 2424
2018
Q3
$87K Hold
1,497
– – 0.01% 939
2018
Q2
$81K Sell
1,497
-1,525
-50% -$83.3K 0.01% 855
2018
Q1
$161K Buy
+3,022
New +$166K 0.01% 597

Other funds holding GSLC

Geneos Wealth Management's GSLC Position: Q2 2026 in Review

Geneos Wealth Management increased its Goldman Sachs ActiveBeta US Large Cap Equity ETF (GSLC) stake by 18% in Q2 2026, buying an estimated $6.5K and bringing the position to 308 shares worth $43.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

Geneos Wealth Management first reported a position in GSLC in Q1 2018 and has held it in 29 quarters since. The position peaked at $161K in Q1 2018. 642 funds tracked by Wall St. Rank hold GSLC as of Q2 2026.

  • Geneos Wealth Management held 308 shares of Goldman Sachs ActiveBeta US Large Cap Equity ETF worth $43.7K as of Q2 2026.
  • Geneos Wealth Management bought 47 Goldman Sachs ActiveBeta US Large Cap Equity ETF shares in Q2 2026, an estimated $6.5K.
  • Goldman Sachs ActiveBeta US Large Cap Equity ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1511 holding.
  • Geneos Wealth Management first reported a position in Goldman Sachs ActiveBeta US Large Cap Equity ETF in Q1 2018 and has held it in 29 quarters since.
  • Geneos Wealth Management's Goldman Sachs ActiveBeta US Large Cap Equity ETF position peaked at $161K in Q1 2018.
  • 642 funds tracked by Wall St. Rank held Goldman Sachs ActiveBeta US Large Cap Equity ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.